Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,102 public trials 617 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Recruiting

Haplo-Cord HSCT for AML/MDS

NCT07588360

Conditions: AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +11 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Sichuan Provincial People's Hospital Chengdu, Sichuan, China

Chinese PLA General Hospital Beijing, China

View Trial Details

Recruiting

Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia

NCT06535113

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: GOM Bianchi Melacrino Morelli Reggio Calabria, Calabria, Italy

IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Recruiting

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

NCT05092451

Conditions: Acute Myeloid Leukemia (AML), B-cell Lymphoma, Blastic Transformation of Chronic Myeloid Leukemia, +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

NCT06236724

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

NCT03586609

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

NCT05360160

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

NCT07450872

Conditions: Cancer, Disease, Glioma, +16 more
Locations: Children's Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

NCT07486713

Conditions: AML (Acute Myeloid Leukemia), Adenocarcinoma, Carcinoma, +15 more
Locations: UCI Irvine Health Orange, California, United States

New York Presbyterian Hospital-Columbia University Medical Center New York, United States

View Trial Details

Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT06131801

Conditions: ALL, AML, Acute Lymphocytic Leukemia, +50 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

NCT05800210

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +30 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions